We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
Cap. Flow
+$985M
Cap. Flow %
13.27%
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$49.3M
2
INTU icon
Intuit
INTU
+$48.7M
3
COST icon
Costco
COST
+$47.9M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$47.4M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$45.1M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$41M
2
DG icon
Dollar General
DG
+$39M
3
BIIB icon
Biogen
BIIB
+$36.8M
4
IYR icon
iShares US Real Estate ETF
IYR
+$29.8M
5
WM icon
Waste Management
WM
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Consumer Discretionary 16.12%
3 Healthcare 11.21%
4 Financials 10.17%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRP
3001
DELISTED
Neurotrope, Inc. Common
NTRP
-50,334
Closed -$58K
BSTC
3002
DELISTED
BioSpecifics Technologies Corp.
BSTC
-4,328
Closed -$265K
HUD
3003
DELISTED
Hudson Ltd. Class A Common Shares
HUD
-65,864
Closed -$321K
AMAG
3004
DELISTED
AMAG Pharmaceuticals
AMAG
-25,400
Closed -$194K
MR
3005
DELISTED
Montage Resources Corporation Common Stock
MR
-25,712
Closed -$102K
HTZ
3006
DELISTED
Hertz Global Holdings, Inc.
HTZ
-114,511
Closed -$161K
IMMU
3007
DELISTED
Immunomedics Inc
IMMU
-105,318
Closed -$3.73M
CETV
3008
DELISTED
Central European Media Enterprises Ltd
CETV
-49,662
Closed -$176K
AMTD
3009
DELISTED
TD Ameritrade Holding Corp
AMTD
-148,761
Closed -$5.41M
MNTA
3010
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
-37,686
Closed -$1.25M
CCMP
3011
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-20,630
Closed -$2.88M
LOGM
3012
DELISTED
LogMein, Inc.
LOGM
-10,519
Closed -$892K
VAL
3013
DELISTED
Valaris plc Class A Ordinary Share
VAL
-21,477
Closed -$14K
CHAP
3014
DELISTED
Chaparral Energy, Inc.
CHAP
-125,110
Closed -$81K
FSB
3015
DELISTED
Franklin Financial Network, Inc.
FSB
-10,219
Closed -$263K
TLRD
3016
DELISTED
Tailored Brands, Inc.
TLRD
-1,080,207
Closed -$1.01M
DNR
3017
DELISTED
Denbury Resources, Inc.
DNR
-504,139
Closed -$139K
NE
3018
DELISTED
Noble Corporation
NE
-11,105
Closed -$4K
LM
3019
DELISTED
Legg Mason, Inc.
LM
-31,107
Closed -$1.55M
TMUSR
3020
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
-11,370
Closed -$2K
BGG
3021
DELISTED
Briggs & Stratton Corp.
BGG
-801,197
Closed -$1.05M
MINI
3022
DELISTED
Mobile Mini Inc
MINI
-40,780
Closed -$1.2M
TECD
3023
DELISTED
Tech Data Corp
TECD
-13,150
Closed -$1.91M
ONCS
3024
DELISTED
OncoSec Medical Incorporated
ONCS
-853
Closed -$38K
CO
3025
DELISTED
Global Cord Blood Corporation
CO
-20,814
Closed -$65K

Similar funds

Squarepoint's Q3 2020 Portfolio in Review

As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.

  • Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
  • Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
  • Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
  • Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
  • Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
  • Squarepoint opened 854 new positions and closed 600 in Q3 2020.
  • Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.

Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.